Pharmacokinetics, safety, and tolerability of paliperidone palmitate 3-month formulation in patients with schizophrenia: A phase-1, single-dose, randomized, open-label study

2015 ◽  
Vol 56 (3) ◽  
pp. 330-339 ◽  
Author(s):  
Paulien Ravenstijn ◽  
Bart Remmerie ◽  
Adam Savitz ◽  
Mahesh N. Samtani ◽  
Isaac Nuamah ◽  
...  
Keyword(s):  
Single Dose ◽  
Phase 1 ◽  
Paliperidone Palmitate ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia

2010 ◽  
Vol 25 (5) ◽  
pp. 685-697 ◽  
Author(s):  
S Gopal ◽  
U Vijapurkar ◽  
P Lim ◽  
M Morozova ◽  
M Eerdekens ◽  
...  
Keyword(s):  
Paliperidone Palmitate ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

Phase 1 open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of dilpacimab in patients with advanced solid tumors

2021 ◽  
pp. molcanther.0985.2020
Author(s):  
Michael S. Gordon ◽  
John Nemunaitis ◽  
Minal Barve ◽  
Zev A. Wainberg ◽  
Erika P. Hamilton ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Advanced Solid Tumors ◽  
Open Label ◽  
Open Label Study ◽  
Label Study

Abstract C37: A Phase 1 open‐label study evaluating pharmacokinetics, safety, and tolerability of linifanib in Japanese patients with solid tumors

2009 ◽  
Author(s):  
Tomohide Tamura ◽  
Noboru Yamamoto ◽  
Hiroshi Nokihara ◽  
Yasuhide Yamada ◽  
Hajime Asahina ◽  
...  
Keyword(s):  
Solid Tumors ◽  
Phase 1 ◽  
Japanese Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study
Sign in / Sign up

Export Citation Format

Share Document